CNTN - Hillstream BioPharma Inc.
3.41
0.040 1.173%
Share volume: 285,141
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$3.37
0.04
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 03-26-2025 | 05-12-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | ||||
| Operating expenses | 2.347 M | 2.373 M | 3.866 M | 3.847 M | 2.547 M | 2.094 M | |
| Selling general and admin | 1.322 M | 1.374 M | 1.584 M | 1.762 M | 1.953 M | 1.816 M | |
| Research and development | 1.025 M | 999.553 K | 2.282 M | 2.085 M | 594.070 K | 277.803 K | |
| Total expenses | 2.347 M | 2.373 M | 3.866 M | 3.847 M | 2.547 M | 2.094 M | |
| 1.11% | 62.87% | -0.47% | -33.81% | -17.79% | |||
| Operating income | -2.347 M | -2.373 M | -3.866 M | -3.847 M | -2.547 M | -2.094 M | |
| Ebit | -2.347 M | -2.373 M | -3.866 M | -3.847 M | -2.547 M | -2.094 M | |
| Pretax income | -2.256 M | -2.325 M | -3.796 M | -3.821 M | -2.542 M | -2.102 M | |
| 3.06% | 63.26% | 0.65% | -33.47% | -17.31% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.256 M | -2.325 M | -3.796 M | -3.821 M | -2.542 M | -2.102 M | |
| -3.06% | -63.26% | -0.65% | 33.47% | 17.31% |